• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORPORATION LIPOSORBER LA-15 SYSTEM; APHERESIS FOR FOCAL GLOMERULOSCLEROSIS IN PEDIATRIC PATIENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORPORATION LIPOSORBER LA-15 SYSTEM; APHERESIS FOR FOCAL GLOMERULOSCLEROSIS IN PEDIATRIC PATIENTS Back to Search Results
Model Number LA-15
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Fever (1858)
Event Date 10/12/2017
Event Type  Injury  
Event Description
A pediatric patient developed focal segmental glomerular sclerosis (fsgs) with steroid resistant nephrotic syndrome.A tunneled.Catheter for blood withdrawing was placed at right internal jugular vein on (b)(6) 2017 for commencing ldl-apheresis using.The liposorber la-15 system.The ldl-apheresis up to 9th on (b)(6) was conducted without any problem in out-patient basis.Since the patient had fever on the next day of 9th ldl-apheresis, she was admitted to the hospital for further examination and medication.Her wbc was 34200/microliter and the result of the blood culture was escherichia coli positive, which was found to become negative after administration of antibiotics.The 12th ldl-apheresis, the final session, on (b)(6) was over without any problem.The attending physician was planning to discharge the patient after removing the catheter.Mfr report #: 3002808904-2017-00005.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIPOSORBER LA-15 SYSTEM
Type of Device
APHERESIS FOR FOCAL GLOMERULOSCLEROSIS IN PEDIATRIC PATIENTS
Manufacturer (Section D)
KANEKA CORPORATION
2-3-18, nakanoshima, kita-ku,
osaka-city, osaka 530-8 288
JA  530-8288
MDR Report Key11635097
MDR Text Key261435997
Report Number2435151-2021-00001
Device Sequence Number1
Product Code PBN
UDI-Device Identifier14993478010110
UDI-Public14993478010110
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 04/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/08/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberLA-15
Device Catalogue NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA04/07/2021
Distributor Facility Aware Date10/13/2017
Event Location Hospital
Date Report to Manufacturer10/13/2017
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening;
Patient Age9 YR
Patient Weight30
-
-